Iridocorneal Endothelial Syndrome: Clinical Perspectives
Overview
Authors
Affiliations
This article aims to review the clinical management strategies available for the rare iridocorneal endothelial syndrome. The different clinical variations as well as the imaging techniques available to aid diagnosis are discussed. We then present the evidence available to help the reader to understand how the condition can be managed medically and also the important surgical aspects of treatment. This involves raised intraocular pressure management in addition to the visual management options of partial or full thickness keratoplasty. We hope that this review provides an exhaustive but also succinct review of the literature available on what is a rare and difficult condition to treat.
Sun Y, Duan X, Fang Y, Tang X BMC Ophthalmol. 2024; 24(1):476.
PMID: 39482590 PMC: 11529484. DOI: 10.1186/s12886-024-03740-y.
Zhou M, Zhu S, Li H, Ye W, Xu S, Lin H Int Ophthalmol. 2024; 44(1):395.
PMID: 39325075 DOI: 10.1007/s10792-024-03211-9.
Pinheiro-Costa J, Coelho-Costa I, Falcao-Reis F, Monteiro T, Falcao M Case Rep Ophthalmol. 2023; 14(1):583-590.
PMID: 37915518 PMC: 10616668. DOI: 10.1159/000534277.
Ruparelia S, Darwich R, Eadie B Am J Ophthalmol Case Rep. 2023; 32:101932.
PMID: 37800094 PMC: 10550507. DOI: 10.1016/j.ajoc.2023.101932.
Zhang J, Peng R, Xiao G, Wang M, Hong J Front Med (Lausanne). 2023; 10:1187009.
PMID: 37484858 PMC: 10357380. DOI: 10.3389/fmed.2023.1187009.